Related Experiment Videos

[Studies on apoptosis of human lung adenocarcinoma cells induced by oltipraz]

H Bai1, X Luo, G Hu

  • 1Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021.

Abstract

Insights

Oltipraz effectively induces apoptosis in human lung adenocarcinoma (GLC-82) cells by arresting the mitotic cycle. This finding offers potential therapeutic insights for lung cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Lung adenocarcinoma is a significant cause of cancer-related mortality.
  • Understanding novel therapeutic agents for lung cancer is crucial.

Purpose of the Study:

  • To investigate the apoptotic effects of oltipraz on human lung adenocarcinoma (GLC-82) cells.
  • To elucidate the underlying mechanism of oltipraz-induced apoptosis.

Main Methods:

  • Utilized light microscopy, DNA electrophoresis, and flow cytometry.
  • Employed video time-lapse monitoring to observe cellular changes.
  • Assessed apoptosis induction in GLC-82 cells treated with oltipraz.

Main Results:

  • Oltipraz treatment led to mitotic arrest at metaphase and an increased percentage of cells in the G(2)/M phase.
  • Observed characteristic apoptotic features including cell shrinkage and DNA fragmentation.
  • The most pronounced apoptotic effect was noted at an oltipraz concentration of 120 µg/ml.

Conclusions:

  • Oltipraz demonstrably induces apoptosis in GLC-82 cells at specific concentrations.
  • The apoptotic process is closely linked to the observed arrest of the mitotic cycle.

Related Concept Videos